Abeona Therapeutics Inc.
ABEO
$6.54
-$0.20-2.97%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -29.44% | 69.30% | -508.71% | 123.45% | -90.33% |
| Total Depreciation and Amortization | 5.03% | 7.48% | 5.40% | -5.39% | 0.42% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.46% | -124.05% | 175.32% | -221.38% | 240.44% |
| Change in Net Operating Assets | 10.79% | -2,055.06% | -107.27% | 186.90% | -377.54% |
| Cash from Operations | -11.13% | -35.35% | 3.55% | 12.75% | -57.42% |
| Capital Expenditure | -131.19% | -50.00% | 43.18% | 1.93% | -1,859.46% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -71.18% | 438.05% | 86.73% | -512.51% | -161.41% |
| Cash from Investing | -77.68% | 406.08% | 86.03% | -464.56% | -167.80% |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 23.33% | -- | -100.00% | 1,048.48% | -17.58% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 84.42% | 33.44% | -2,035.71% | 98.57% | -206.27% |
| Cash from Financing | 27.36% | 1,877.26% | -100.41% | 189.64% | 240.70% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -197.25% | 140.81% | -210.86% | 446.77% | -68.39% |